|Day Low/High||190.22 / 195.00|
|52 Wk Low/High||181.02 / 459.75|
NEW YORK, Aug. 9, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Abiomed, Inc.
NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abiomed, Inc.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Abiomed, Inc.
Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of Abiomed, Inc.
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abiomed, Inc.
NEW YORK, Aug. 7, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of shareholders of Abiomed, Inc.
NEW YORK, Aug. 7, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Abiomed, Inc.
NEW YORK, Aug. 6, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abiomed, Inc.
New training programs, organizational changes in distribution, and certain external initiatives implemented in the first quarter 'will require time to drive more growth,' the CEO says.
ABMD has been one of the best-performing stocks in the S&P 500 over the past five years.
Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, August 1, 2019, the Company will release financial results for the first quarter of fiscal 2020.
Jim Cramer says save the bubble-talk for the bathtub. The money investors can make in the market is real, and due to ingenuity, competitiveness and economic growth.
Abiomed's (NASDAQ:ABMD) Impella platform is being featured today at a Washington, D.
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R.
In a letter sent to healthcare providers today, the U.S.
Abiomed (NASDAQ:ABMD) announces today that the Impella CP with SmartAssist, which is designed to improve patient outcomes with advanced algorithms and simplified patient management, will be commercially available beginning at the 2019 Society for...
The medical device maker rebounded from much bigger losses earlier in the day, however.
Abiomed (NASDAQ: ABMD) announces that, on April 26, the FDA approved initiation of the ST-Elevation Myocardial Infarction Door-to-Unloading (STEMI DTU) Pivotal Randomized Controlled Trial.
New research adds to 12 years of real-world data and FDA studies demonstrating the use of Abiomed's (NASDAQ: ABMD) Impella heart pumps during high-risk PCI (Protected PCI) enables skilled interventional cardiologists to achieve more complete...
Breadth looks like it did in late February as the McClellan Summation Index starts to roll over -- from a lower high.
Cramer says these red-hot and hopelessly overvalued IPOs are signs people are too bullish. Here's your game plan for next week.
Jim Cramer takes a closer look at Kraft Heinz, PepsiCo, Marvell Technology, General Mills, Funko, Signet Jewelers, Abiomed and more.
Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, May 2, 2019, the Company will release financial results for the fourth quarter of fiscal 2019.
Three years ago this week, Abiomed's (NASDAQ: ABMD) Impella heart pump received its FDA PMA approval for AMI cardiogenic shock.
The biggest IPO of the year so far is likely to set a trend, Jim Cramer says.
Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies and the maker of the Impella RP heart pump, announces that survival data from the 18 month post-approval study of 42 Impella RP patients was presented at the American...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.